Tempest Therapeutics, Inc. — Director's Dealing 2015

Jul 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2015-06-30

Reporting Person: Stock Harald F. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-30	Common Stock	A	414	$28.93	Acquired	759	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13022	Indirect

Footnotes

F1: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F2: By SB Vermogensverwaltungs KG, a trust of which the reporting person is a majority shareholder and managing partner.